JP2008515980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515980A5 JP2008515980A5 JP2007536818A JP2007536818A JP2008515980A5 JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5 JP 2007536818 A JP2007536818 A JP 2007536818A JP 2007536818 A JP2007536818 A JP 2007536818A JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5
- Authority
- JP
- Japan
- Prior art keywords
- osamu
- prostaglandins
- prevention
- ester
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003180 prostaglandins Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61820204P | 2004-10-12 | 2004-10-12 | |
| PCT/US2005/036558 WO2006044405A1 (en) | 2004-10-12 | 2005-10-11 | Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008515980A JP2008515980A (ja) | 2008-05-15 |
| JP2008515980A5 true JP2008515980A5 (OSRAM) | 2008-11-27 |
Family
ID=35677621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007536818A Pending JP2008515980A (ja) | 2004-10-12 | 2005-10-11 | 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20060142348A1 (OSRAM) |
| EP (1) | EP1812426B1 (OSRAM) |
| JP (1) | JP2008515980A (OSRAM) |
| KR (1) | KR20070085340A (OSRAM) |
| CN (1) | CN101076529A (OSRAM) |
| AT (1) | ATE512144T1 (OSRAM) |
| AU (1) | AU2005295902A1 (OSRAM) |
| BR (1) | BRPI0517417A (OSRAM) |
| CA (1) | CA2583710A1 (OSRAM) |
| IL (1) | IL182489A0 (OSRAM) |
| MX (1) | MX2007004526A (OSRAM) |
| NO (1) | NO20072269L (OSRAM) |
| NZ (1) | NZ554493A (OSRAM) |
| RU (1) | RU2407736C2 (OSRAM) |
| SG (1) | SG156637A1 (OSRAM) |
| WO (1) | WO2006044405A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| KR20080023680A (ko) | 2005-05-10 | 2008-03-14 | 인터뮨, 인크. | 스트레스-활성화 단백질 키나제 시스템을 조절하기 위한피리돈 유도체 |
| US20090163586A1 (en) | 2007-12-20 | 2009-06-25 | Astrazeneca Ab | Bis-(Sulfonylamino) Derivatives in Therapy 205 |
| EP2296653B1 (en) | 2008-06-03 | 2016-01-27 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| FR2938538B1 (fr) * | 2008-11-17 | 2011-08-05 | Univ Nice Sophia Antipolis | Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique |
| CA2756870A1 (en) | 2009-03-31 | 2010-10-07 | Arqule, Inc. | Substituted indolo-pyridinone compounds |
| JP5841361B2 (ja) * | 2011-06-29 | 2016-01-13 | 壽製薬株式会社 | 三環性化合物及びそれを含有する医薬組成物 |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| JP6749234B2 (ja) * | 2013-09-27 | 2020-09-02 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 皮膚修復のための化合物及び方法 |
| JP6525437B2 (ja) | 2014-04-02 | 2019-06-05 | インターミューン， インコーポレイテッド | 抗線維性ピリジノン |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| GB201810581D0 (en) | 2018-06-28 | 2018-08-15 | Ctxt Pty Ltd | Compounds |
| PL4299135T3 (pl) | 2019-06-18 | 2025-11-12 | Pfizer Inc. | Pochodne benzizoksazolosulfonamidu |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU711592B2 (en) * | 1995-04-03 | 1999-10-14 | Novartis Ag | Pyrazole derivatives and processes for the preparation thereof |
| ZA984040B (en) * | 1997-05-15 | 1998-11-20 | Ono Pharmaceutical Co | Benzenesulfonamide compounds |
| EA200200411A1 (ru) * | 1999-11-30 | 2002-10-31 | Пфайзер Продактс Инк. | 2,4-диаминопиримидиновые соединения, полезные в качестве иммуносупрессоров |
| EP1431267A4 (en) * | 2001-08-09 | 2004-12-22 | Ono Pharmaceutical Co | COMPOUNDS DERIVED FROM CARBOXYLIC ACID AND MEDICAMENTS COMPRISING SUCH COMPOUNDS AS ACTIVE INGREDIENT |
| WO2004078719A1 (ja) * | 2003-03-06 | 2004-09-16 | Ono Pharmaceutical Co., Ltd. | インドール誘導体化合物およびその化合物を有効成分とする薬剤 |
| WO2005005415A1 (en) * | 2003-07-09 | 2005-01-20 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| ES2527118T3 (es) * | 2003-12-19 | 2015-01-20 | Plexxikon Inc. | Compuestos y procedimientos de desarrollo de moduladores de Ret |
-
2005
- 2005-10-11 JP JP2007536818A patent/JP2008515980A/ja active Pending
- 2005-10-11 NZ NZ554493A patent/NZ554493A/en not_active IP Right Cessation
- 2005-10-11 WO PCT/US2005/036558 patent/WO2006044405A1/en not_active Ceased
- 2005-10-11 AU AU2005295902A patent/AU2005295902A1/en not_active Abandoned
- 2005-10-11 BR BRPI0517417-1A patent/BRPI0517417A/pt not_active IP Right Cessation
- 2005-10-11 US US11/247,456 patent/US20060142348A1/en not_active Abandoned
- 2005-10-11 AT AT05812269T patent/ATE512144T1/de not_active IP Right Cessation
- 2005-10-11 CA CA002583710A patent/CA2583710A1/en not_active Abandoned
- 2005-10-11 KR KR1020077010839A patent/KR20070085340A/ko not_active Ceased
- 2005-10-11 RU RU2007115520/04A patent/RU2407736C2/ru not_active IP Right Cessation
- 2005-10-11 MX MX2007004526A patent/MX2007004526A/es unknown
- 2005-10-11 CN CNA200580042679XA patent/CN101076529A/zh active Pending
- 2005-10-11 SG SG200906805-7A patent/SG156637A1/en unknown
- 2005-10-11 EP EP05812269A patent/EP1812426B1/en not_active Expired - Lifetime
-
2007
- 2007-04-11 IL IL182489A patent/IL182489A0/en unknown
- 2007-05-02 NO NO20072269A patent/NO20072269L/no not_active Application Discontinuation
-
2008
- 2008-11-03 US US12/264,053 patent/US20090075985A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007501251A5 (OSRAM) | ||
| JP2003520232A5 (OSRAM) | ||
| JP2008515980A5 (OSRAM) | ||
| JP2003503454A5 (OSRAM) | ||
| JP2007523049A5 (OSRAM) | ||
| JP2008513467A5 (OSRAM) | ||
| JP2012502037A5 (OSRAM) | ||
| JP2006517944A5 (OSRAM) | ||
| JP2010528011A5 (OSRAM) | ||
| JP2009538898A5 (OSRAM) | ||
| ME02688B (me) | Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta | |
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| JP2006503588A5 (OSRAM) | ||
| WO2007093642A3 (fr) | Formes pharmaceutiques multimicroparticulaires qui resistent a la decharge immediate du principe actif en presence d'alcool | |
| BRPI0618211B8 (pt) | composição farmacêutica contendo pregabalina para dosagem uma vez ao dia e uso do referido composto | |
| JP2010535814A5 (OSRAM) | ||
| JP2008505857A5 (OSRAM) | ||
| JP2007520565A5 (OSRAM) | ||
| CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
| JP2005513006A5 (OSRAM) | ||
| JP2008513510A5 (OSRAM) | ||
| JP2011527299A5 (OSRAM) | ||
| JP2007523135A5 (OSRAM) | ||
| DE602008006243D1 (de) | Pharmazeutische kombination aus aliskiren und valsartan | |
| DE60336225D1 (de) | Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend |